N Shinagawa
- Co-authors
- Y ArabiD. W. BurdonR.H. GeorgeJ Alexander-WilliamsJoel D. BrownM R B KeighleyJ SymondsH Thompson
- Topics
- Antibiotics Pharmacokinetics and Efficacy (5 papers)Clostridium difficile and Clostridium perfringens research (3 papers)Gastrointestinal motility and disorders (2 papers)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
N Shinagawa
27 papers receiving 535 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Infectious Diseases 443
- Epidemiology 221
- Surgery 93
- Molecular Biology 86
- Pulmonary and Respiratory Medicine 58
Countries citing papers authored by N Shinagawa
This map shows the geographic impact of N Shinagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Shinagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Shinagawa more than expected).
Fields of papers citing papers by N Shinagawa
This network shows the impact of papers produced by N Shinagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Shinagawa. The network helps show where N Shinagawa may publish in the future.
Co-authorship network of co-authors of N Shinagawa
This figure shows the co-authorship network connecting the top 25 collaborators of N Shinagawa. A scholar is included among the top collaborators of N Shinagawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Shinagawa. N Shinagawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 4 | |
| 7 | [Identification and antibiotic prophylaxis of high-risk patients in biliary tract surgery]. | 1 |
| 8 | 2 | |
| 9 | [Complication of the central vein catheterization]. | 0 |
| 10 | [Anthropometric measurement]. | 35 |
| 11 | Comparative pharmacokinetics of ceftriaxone, cefmetazole and moxalactam during abdominal surgery. | 6 |
| 12 | [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor]. | 5 |
| 13 | [Clinical assessment of sulbactam/cefoperazone in comparison with ceftizoxime in patients with postoperative infections by well controlled method]. | 1 |
| 14 | Identification of Clostridium difficile as a cause of pseudomembranous colitis.breakdown → | 354 |
| 15 | 62 | |
| 16 | 40 | |
| 17 | [Definition of midwifery]. | 1 |
| 18 | [Fundamental and clinical studies of amikacin (BB-K8) in surgical field (author's transl)]? | 1 |
| 19 | [Hemorrhage in obstetrics]. | 6 |
| 20 | [Incidence of complications of gastric cancer in pregnancy]. | 1 |
About N Shinagawa
N Shinagawa is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Gastroenterology, having authored 31 papers that have together received 612 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Clostridium difficile and Clostridium perfringens research (3 papers) and Gastrointestinal motility and disorders (2 papers). The work is most often cited by research in Infectious Diseases (443 citations), Critical Care and Intensive Care Medicine (57 citations) and Gastroenterology (55 citations). N Shinagawa has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Y Arabi, D. W. Burdon, R.H. George, J Alexander-Williams, Joel D. Brown, M R B Keighley, J Symonds, M R B Keighley, H Thompson and Denise Youngs. Their work appears in journals such as The Lancet, Free Radical Biology and Medicine and British journal of surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.